‘Text/HTML’ of page ‘NRG-BR007: The Debra Trial’
Frequently Asked Questions Below, you can find FAQs about clinical research and this particular clinical trial.
Read MoreContent Block Tag: NRG-BR007: The Debra Trial
‘Text/HTML’ of page ‘NRG-BR007: The Debra Trial’
Am I eligible for this study? If you have low-risk early-stage breast cancer that is sensitive to hormone treatment, have had a lumpectomy and have an Oncotype Dx Recurrence Score equal to or less than 18, you may be able to participate. If you have not yet received an Oncotype Recurrence Score, you may still […]
Read More‘Text/HTML’ of page ‘NRG-BR007: The Debra Trial’
About This Study NRG-BR007, also known as the “DEBRA” trial, is a clinical study looking at safely reducing the use of breast radiation after lumpectomy for people with low-risk, early-stage breast cancer. The study is seeking to determine if, in comparison to the usual treatment of breast radiation and hormonal therapy, a more conservative treatment […]
Read More‘Text/HTML’ of page ‘NRG-BR007: The Debra Trial’
Clinical Studies FAQ
Read More‘Text/HTML’ of page ‘NRG-BR007: The Debra Trial’
THE DEBRA STUDY FAQ
Read More